Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.95 - $4.84 $1,836 - $2,250
-465 Closed
0 $0
Q1 2020

Aug 13, 2024

SELL
$22.18 - $28.78 $4,436 - $5,756
-200 Closed
0 $0
Q2 2019

Aug 13, 2024

SELL
$15.32 - $23.65 $7,506 - $11,588
-490 Reduced 71.01%
200 $3.13 Million
Q1 2019

Aug 13, 2024

BUY
$20.5 - $24.32 $14,145 - $16,780
690 New
690 $15.7 Million
Q3 2018

Aug 13, 2024

BUY
$33.01 - $44.57 $6,106 - $8,245
185 Added 45.68%
590 $19.5 Million
Q2 2018

Aug 13, 2024

SELL
$33.46 - $46.17 $2,007 - $2,770
-60 Reduced 12.9%
405 $17.8 Million
Q1 2018

Aug 14, 2024

BUY
$41.2 - $53.24 $19,158 - $24,756
465 New
465 $19.4 Million
Q1 2018

Aug 13, 2024

BUY
$41.2 - $53.24 $3,914 - $5,057
95 Added 25.68%
465 $19.4 Million
Q4 2017

Aug 13, 2024

BUY
$34.19 - $48.11 $12,650 - $17,800
370
370 $16.8 Million

Others Institutions Holding PETS

About PETMED EXPRESS INC


  • Ticker PETS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 21,013,800
  • Market Cap $84.7M
  • Description
  • PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...
More about PETS
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.